3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Prostatic Neoplasms
3
Uterine Cervical Dysplasia
2
Thyroid Nodule
2
Sarcoma
2
Papillomavirus Infections
2
Melanoma
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Spinal Cord Compression
1
Recurrence
1
Prostatic Hyperplasia
1
Precancerous Conditions
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Unknown Primary
1
Neoplasms by Site
1
Neoplasms
1
Liver Neoplasms
1
Hyperthyroidism
1
HIV Infections
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Gastrointestinal Neoplasms
1
Interventions
niraparib
2
anlotinib
2
Robotic Surgical Procedures
2
Paclitaxel
2
Carboplatin
2
Bevacizumab
2
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
2
temsirolimus
1
olaparib
1
carboprost tromethamine
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Trabectedin
1
Preoperative Care
1
Pregnancy Tests
1
Postoperative Care
1
Ocoxin
1
Laparoscopy
1
Intraoperative Care
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Human Papillomavirus DNA Tests
1
GX-188 vaccine
1
Filgrastim
1
Diffusion
1
Dexamethasone
1
Colposcopy
1
CP protocol
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Genital Diseases, Female
×
Transurethral Resection of Prostate
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled